News

Merck & Co. has received a positive opinion from the EMEA’s Committee for Medicinal Products for Human Use (CHMP) for Januvia tablets and Janumet tablets recommending their use

Focetria, the Novartis Influenza A(H1N1) 2009 monovalent vaccine, has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the EMEA. Reportedly, the

The FDA has granted accelerated approval for Allos Therapeutics’ FOLOTYN(pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell

Bioniche Pharma and Synerx Pharma, have launch of Fomepizole Injection, which is the generic equivalent of Paladin Labs’ Antizol. George Zorich, president for US Operations at Bioniche Pharma,

S&P Consultants and Vedant has entered into a business partnership, which to offer quality- and patient-safety assurance to both standard and customised applications built on the Cerner Millennium

Centocor Ortho Biotech has announced that the FDA has approved Stelara (ustekinumab) for the treatment of adult patients 18 years or older with moderate to severe plaque psoriasis

NicOx has announced that a New Drug Application (NDA) for naproxcinod has been submitted to the FDA, seeking approval for an indication for the relief of the signs

“Just weeks ago we received clearance from the US Treasury Department to extend our US clinical program for nimotuzumab, permitting us to conduct trials in any cancer indication.

Active Biotech’s prostate cancer project TASQ, where TASQ was studied as a single agent in patients with castration-resistant prostate cancer, was published in British Journal of Cancer. Two